Cargando…
Latent Myofascial Trigger Points Injection Reduced the Severity of Persistent, Moderate to Severe Allergic Rhinitis: A Randomized Controlled Trial
Background: Myofascial trigger points (MTrPs) injection has been effectively used for the management of chronic painful diseases. Latent MTrPs can induce autonomic nerve phenomena. In our clinic, we observed that allergic rhinitis (AR) symptoms significantly improved when latent MTrPs injection was...
Autores principales: | Liu, Yu, Yang, Yan, Hu, Qiya, Badughaish, Ahmed, Zhang, Hanbing, Qi, Feng, Hou, Yuedong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517181/ https://www.ncbi.nlm.nih.gov/pubmed/34660639 http://dx.doi.org/10.3389/fmed.2021.731254 |
Ejemplares similares
-
Latent myofascial trigger points injection therapy for adult cough variant asthma: A randomized controlled trial
por: Liu, Qianqian, et al.
Publicado: (2023) -
Sleep disorders in children with moderate to severe persistent allergic rhinitis()
por: Loekmanwidjaja, Jessica, et al.
Publicado: (2017) -
The pathophysiological nature of sarcomeres in trigger points in patients with myofascial pain syndrome: A preliminary study
por: Jin, Feihong, et al.
Publicado: (2020) -
Correlation of acidic mammalian chitinase expression with disease severity in patients with moderate/severe persistent allergic rhinitis
por: SADEGHI, HAMID REZA, et al.
Publicado: (2020) -
Ischemic Compression After Trigger Point Injection Affect the Treatment of Myofascial Trigger Points
por: Kim, Soo A, et al.
Publicado: (2013)